Search Results - "Preusser, M."

Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up by Jordan, B., Margulies, A., Cardoso, F., Cavaletti, G., Haugnes, H.S., Jahn, P., Le Rhun, E., Preusser, M., Scotté, F., Taphoorn, M.J.B., Jordan, K.

“…•This ESMO–EONS–EANO Clinical Practice Guideline provides key recommendations on the management of therapy-induced peripheral and central…”
Get full text

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours by Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A.S., Metellus, P., Peters, S., Hong, Y.-K., Winkler, F., Schadendorf, D., van den Bent, M., Seoane, J., Stahel, R., Minniti, G., Wesseling, P., Weller, M., Preusser, M.

“…•This Clinical Practice Guideline provides management recommendations for patients with brain metastases from solid tumours.•The guideline covers clinical and…”
Get full text

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours by Le Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., Wesseling, P., Rudà, R., Preusser, M.

Get full text

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning by Klauschen, F., Müller, K.-R., Binder, A., Bockmayr, M., Hägele, M., Seegerer, P., Wienert, S., Pruneri, G., de Maria, S., Badve, S., Michiels, S., Nielsen, T.O., Adams, S., Savas, P., Symmans, F., Willis, S., Gruosso, T., Park, M., Haibe-Kains, B., Gallas, B., Thompson, A.M., Cree, I., Sotiriou, C., Solinas, C., Preusser, M., Hewitt, S.M., Rimm, D., Viale, G., Loi, S., Loibl, S., Salgado, R., Denkert, C.

“…The extent of tumor-infiltrating lymphocytes (TILs), along with immunomodulatory ligands, tumor-mutational burden and other biomarkers, has been demonstrated…”
Get full text

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism by Mir Seyed Nazari, P., Riedl, J., Preusser, M., Posch, F., Thaler, J., Marosi, C., Birner, P., Ricken, G., Hainfellner, J. A., Pabinger, I., Ay, C.

“…Essentials Risk stratification for venous thromboembolism (VTE) in patients with brain tumors is challenging. Patients with IDH1 wildtype and high podoplanin…”
Get full text

Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey by Banerjee, S., Califano, R., Corral, J., de Azambuja, E., De Mattos-Arruda, L., Guarneri, V., Hutka, M., Jordan, K., Martinelli, E., Mountzios, G., Ozturk, M.A., Petrova, M., Postel-Vinay, S., Preusser, M., Qvortrup, C., Volkov, M.N.M., Tabernero, J., Olmos, D., Strijbos, M.H.

“…Burnout in health care professionals could have serious negative consequences on quality of patient care, professional satisfaction and personal life. Our aim…”
Get full text

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up by Roth, P., Pace, A., Le Rhun, E., Weller, M., Ay, C., Cohen-Jonathan Moyal, E., Coomans, M., Giusti, R., Jordan, K., Nishikawa, R., Winkler, F., Hong, J.T., Ruda, R., Villà, S., Taphoorn, M.J.B., Wick, W., Preusser, M.

“…•This EANO-ESMO Clinical Practice Guideline provides key recommendations on the management of neurological and vascular complications of brain…”
Get full text

Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy by Fendl, B., Berghoff, A.S., Preusser, M., Maier, B.

“…The introduction of immune checkpoint inhibitors (ICIs) for the treatment of solid cancers dramatically turned the tables in clinical routine. However, therapy…”
Get full text

Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14 by Deng, M. Y., Sill, M., Sturm, D., Stichel, D., Witt, H., Ecker, J., Wittmann, A., Schittenhelm, J., Ebinger, M., Schuhmann, M. U., Figarella‐Branger, D., Aronica, E., Staszewski, O., Preusser, M., Haberler, C., Lauten, M., Schüller, U., Hartmann, C., Snuderl, M., Dunham, C., Jabado, N., Wesseling, P., Deckert, M., Keyvani, K., Gottardo, N., Giangaspero, F., Hoff, K., Ellison, D. W., Pietsch, T., Herold-Mende, C., Milde, T., Witt, O., Kool, M., Korshunov, A., Wick, W., Deimling, A., Pfister, S. M., Jones, D. T. W., Sahm, F.

“…Aims DNA methylation‐based central nervous system (CNS) tumour classification has identified numerous molecularly distinct tumour types, and clinically…”
Get full text

ESMO Open: from Cancer Horizons to Science for Optimal Cancer Care-a tale stretching over 8 years by Zielinski, C, Preusser, M, Berghoff, A

Get full text

Reply to the letter to the editor ‘Can we trust burnout research?’ by Bianchi et al by Banerjee, S., Preusser, M., Tabernero, J., Strijbos, M.

Get full text

The landscape of medical oncology in Europe by 2020 by de Azambuja, E., Ameye, L., Paesmans, M., Zielinski, C.C., Piccart-Gebhart, M., Preusser, M.

“…In the United States, there will be a shortage of medical oncologists (MO) by 2020. However, this information is not available for Europe. The aim of this…”
Get full text

Applied Precision Cancer Medicine in Neuro-Oncology by Taghizadeh, H., Müllauer, L., Furtner, J., Hainfellner, J. A., Marosi, C., Preusser, M., Prager, G. W.

“…Brain tumours that are refractory to treatment have a poor prognosis and constitute a major challenge in offering effective treatment strategies. By targeting…”
Get full text

A comparison of the utilization and efficacy of palliative chemotherapy for the treatment of locally advanced or metastatic gastroesophageal carcinoma: a retrospective single-center analysis by Baumgartner, R., Taghizadeh, H., Jomrich, G., Schoppmann, S., Preusser, M., Ilhan-Mutlu, A.

Get full text

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center by Füreder, L. M., Widhalm, G., Gatterbauer, B., Dieckmann, K., Hainfellner, J. A., Bartsch, R., Zielinski, C. C., Preusser, M., Berghoff, A. S.

“…Symptomatic brain metastases (BM) are a frequent and late complication in cancer patients. However, a subgroup of cancer patients presents with BM as the first…”
Get full text

The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma by Flechl, B., Sax, C., Ackerl, M., Crevenna, R., Woehrer, A., Hainfellner, J., Preusser, M., Widhalm, G., Kiesel, B., Lütgendorf-Caucig, C., Dieckmann, K., Steffal, C., Marosi, C., Hassler, M.R.

“…The importance of QoL and neurocognitive functions in patients with glioblastoma (GB) is above controversy by now. We followed newly diagnosed GB patients…”
Get full text

Introducing pro and con discussions in ESMO Open—Cancer Horizons by Zielinski, C., Preusser, M., Berghoff, A.

Get full text

IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee by Preusser, M, Capper, D, Hartmann, C

“…Isocitrate dehydrogenase 1 (IDH1) gene mutations, primarily of the R132H type, occur in approximately 60 - 90% of diffuse and anaplastic gliomas and secondary…”
Get more information

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up by Le Rhun, E., Weller, M., van den Bent, M., Brandsma, D., Furtner, J., Rudà, R., Schadendorf, D., Seoane, J., Tonn, J.-C., Wesseling, P., Wick, W., Minniti, G., Peters, S., Curigliano, G., Preusser, M.

“…•This Clinical Practice Guideline provides recommendations for managing leptomeningeal metastases from solid tumours.•The guideline covers clinical, imaging…”
Get full text

Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma by Furtner, J, Schöpf, V, Preusser, M, Asenbaum, U, Woitek, R, Wöhrer, A, Hainfellner, J.A, Wolfsberger, S, Prayer, D

“…Abstract Using conventional MRI methods, the differentiation of primary cerebral lymphomas (PCNSL) and other primary brain tumors, such as glioblastomas, is…”
Get full text